TCL Archive PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract February 17, 1995
TCL Archive DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial October 13, 1995
TCL Archive IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies May 8, 1987
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive OMB reviewing Administration’s Reauthorization Bill; NCI Special Authority Probably Will Remain April 15, 1988